Despite side effects from the first dose, he followed through with the second dose. Clapton was previously diagnosed with peripheral neuropathy, which causes nerve damage in the arms and legs that can result in pain, burning, numbness, and the feeling of pins-and-needles. Following his second dose, Clapton lost the use of his hands almost completely….
Month: August 2021
Aesthetics Advisor reports “Hydroxychloroquine vs Ivermectin vs Quercetin: What are the Differences?”
If you are confused about the recommendations made by different professional groups for the COVID-19 pandemic, you’ve come to the right place. Before you continue to read this rather long article, let’s start with the end in mind and begin with the conclusion that you may have been told. There is no early treatment for…
One Day MD reports “Dr Richard Bartlett Inhaled Budesonide Protocol for COVID-19”
In April 2021, The Lancet reported evidence of UK’s first effective drug to treat COVID-19 in patients at home, inhaled budesonide, showing the treatment can reduce recovery time by a median of three days. The treatment has since been included in clinical guidelines for treating early-stage COVID-19 across the UK, Canada and India. Dr. Richard Bartlett shared…
Children’s Health Defense reports “Actress Sally Kirkland After Moderna Vaccine: In My 79 Years, I’ve Never Experienced This Level of Pain”
Immediately after her second Moderna shot, award-winning actress Sally Kirkland knew something was wrong — five months later, she remains in almost constant pain. Sally Kirkland has been acting since she was 17, and has appeared in more than 250 movies. But she didn’t sign up for the role she’s playing now — an advocate…
Trial Site News reports “Ivermectin: Pros vs Cons. Dr. Luis Garegnani and Dr. Pierre Kory Debate The Issue”
Dr. Luis Garegnani from Argentia wrote an opinion piece on Ivermectin not having enough evidence behind it in BMJ Journals. Dr. Pierre Kory of the FLCCC disagrees. Both doctors debate this issue with Dr. Erin Stair as the moderator. About Luis Garegnani: Luis Garegnani is a Professor of Research methods and evidence-based medicine at Instituto…
Open Forum Infectious Disease reports “Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection”
Ivermectin is an antiparasitic drug being investigated for repurposing against SARS-CoV-2. Ivermectin showed in-vitro activity against SARS-COV-2 at high concentrations. This meta-analysis investigated ivermectin in 24 randomized clinical trials (3328 patients) identified through systematic searches of PUBMED, EMBASE, MedRxiv and trial registries. Ivermectin was associated with reduced inflammatory markers (C-Reactive Protein, d-dimer and ferritin) and…
Research Square reports “Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic”
Up-to-date, there is no recognized effective treatment or vaccine for the treatment of COVID-19 that emphasize urgency around distinctive effective therapies. This study aims to evaluate the anti-parasitic medication efficacy “Ivermectin” plus standard care ((Azithromycin, vitamin C, Zinc, Lactoferrin & Acetylcystein & prophylactic or therapeutic anticoagulation if D-dimer > 1000)) in the treatment of mild/moderate and severely…
Cell Reports Medicine reports “Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells”
Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of >200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers…